{"url":"https://lda.senate.gov/api/v1/filings/4fb5fca8-eb40-487f-b60c-44286e0fbf10/","filing_uuid":"4fb5fca8-eb40-487f-b60c-44286e0fbf10","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2018,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/4fb5fca8-eb40-487f-b60c-44286e0fbf10/print/","filing_document_content_type":"text/html","income":"52500.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mary Beth Savary Taylor","dt_posted":"2019-01-18T11:25:03.717000-05:00","termination_date":"2018-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St. NW","registrant_address_2":"Suite 250 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":293335,"url":"https://lda.senate.gov/api/v1/registrants/293335/","house_registrant_id":37338,"name":"THE NICKLES GROUP, LLC","description":"Consulting firm.","address_1":"601 13th St. NW","address_2":"Suite 250 N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHLEEN MCGHEE","contact_telephone":"+1 202-742-6990","dt_updated":"2026-07-06T11:19:03.627222-04:00"},"client":{"id":178559,"url":"https://lda.senate.gov/api/v1/clients/178559/","client_id":1005305,"name":"SHIRE PHARMACEUTICALS LLC","general_description":"Biotechnology company.","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-06-03"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act of 2019.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58251,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66112,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"RAAB","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":13,"name":"Office of the Vice President of the United States"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitor implementation of The Tax Cut and Jobs Act, as it relates to corporate tax reform, the taxation of multinationals, and the orphan drug tax credit.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":13,"name":"Office of the Vice President of the United States"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Orphan Drug Act and issues regarding access to care for those with rare diseases. H.R. 5803, SAFETY Act of 2018, S. 2680, Opioid Crisis Response Act of 2018, S. 2891, Fighting the Opioid Epidemic with Sunshine Act of 2018, S. 3000, Patient Advocacy Transparency Act, and H.R. 6, SUPPORT for Patients and Communities Act as they related to issues regarding controlled substances. Monitored issues related to newborn screening.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58251,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66112,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"RAAB","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":13,"name":"Office of the Vice President of the United States"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids) and H.R. 7212, IMPROVE Act. S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58251,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"PORTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66112,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"RAAB","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":13,"name":"Office of the Vice President of the United States"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}